Impact of sirolimus duration on hepatitis C related fibrosis progression in liver transplant recipients.
M
M
Kim
M P
MP
Curry
C C
CC
Rogers
D005260:Female; D006526:Hepatitis C / Q000517:prevention & control*; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D020123:Sirolimus / Q000627:therapeutic use*
D020123:Sirolimus